Bosaya(TM) and Aukelso(TM) (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with an interchangeable designation -- Potential benefit to ...
Using an LPS-induced ALI mouse model and LPS-stimulated alveolar macrophages, they found XBJ reduced inflammatory cytokine ...
Far more than a superficial epithelial problem, corneal melt is a progressive ulceration of corneal stromal tissue that can compromise the structural integrity of the eye. Corneal melt often precedes ...
Bosaya™ and Aukelso™ (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with an interchangeable designationPotential benefit to the ...
Cancer and cancer treatments can make it more likely for you to get an infection. There are many different types of ...
Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results